| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |